Business modelsB2B

Products 31 to 40 of 162

Biotech components: Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:18 (4 years ago)
Date last modified: 2019/09/12 15:18 (4 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medical Treatment + Medicine
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
BioIsoprene by DuPont
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Biotech components: Bacteria
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:35 (3 years ago)
Date last modified: 2020/12/18 14:35 (3 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Food & Agriculture
Market status: Under Development + Early Stage Concept
Organization type(s): Private Company
Product categories: Other
Production process: Open Release
Source: Web search
Trading symbol: ALMIB (EPA)
Value chain stage: Finished Product
Biotech components: N/A
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (5 years ago)
Date last modified: 2018/11/19 09:36 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: Early Stage Concept + More information needed
Organization type(s): Private Company
Product categories: Construction + Design + Resource Extraction
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Microbe
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 3,498,401 USD
Funding types: Government
Industry: Science
Market status: Early Stage Concept
Organization type(s): University
Product categories: Research
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Platform
Biolon DDDA by Verdezyne
Biotech components: Plant
Business models: B2B
Country of production: Malaysia
Country of distribution: Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/11/08 14:44 (5 years ago)
Known funding amount: 86,500,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biopolymer I6001 by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/10/01 09:56 (5 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer I6003rp by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/10/01 09:56 (5 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5010 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5011 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input